Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Daniel Tomas Hernandez, M.D.

Concepts (15)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Anilides120174080.120 Why?
fms-Like Tyrosine Kinase 3120174970.110 Why?
Pyridines1201728670.060 Why?
Leukemia, Myeloid, Acute1201735960.050 Why?
Protein Kinase Inhibitors1201755980.050 Why?
Maximum Tolerated Dose120178740.030 Why?
Mutation12017297120.030 Why?
Drug Resistance, Neoplasm1201751640.010 Why?
Aged, 80 and over12017583470.010 Why?
Aged120171667050.000 Why?
Middle Aged120172172500.000 Why?
Adult120172171680.000 Why?
Male120173551600.000 Why?
Female120173863390.000 Why?
Humans120177528100.000 Why?
Hernandez's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (15)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.